$AKAN

12 Health Care Stocks Moving In Thursday's Intraday Session

This article details the intraday movements of 12 health care stocks on Thursday, highlighting both gainers and losers. Notable gainers include Agape ATP, Akanda, and Co-Diagnostics, with significant percentage increases, while stocks like WORK Medical Tech Gr, Wellgistics Health, and Indaptus Therapeutics experienced declines. The article provides market cap and recent earnings report dates for several of the mentioned companies.

Original reporting
Benzinga · Benzinga Staff Writer
Published May 22, 2026, 2:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 22, 2026, 3:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
12 Health Care Stocks Moving In Thursday's Intraday Session — source image
Decision brief

The 30-second read

$AKANNeutralLow
01

Why it matters

The intraday movements are typical and may not reflect fundamental changes; traders should interpret with caution.

02

Market read

The intraday movements are relevant for short-term traders focusing on healthcare stocks but have limited impact on broader market strategies.

03

What to watch

Broader industry developments and upcoming earnings reports could have a more substantial impact than intraday stock movements.

Timing: short-term

Background

The article reports intraday movements of 12 healthcare stocks, with some stocks showing notable gains or losses.

Company-level read

Ticker impact

$AKANNeutralMedium confidence
Context

Low relevance due to minimal sentiment impact and limited intraday movement.

Expected impact

Likely negligible price change, possibly within ±1%.

Evidence & confidence

The sentiment score is neutral, and the relevance score is low, suggesting limited influence on trading decisions.

Market effects

Potential minor influence on healthcare sector sentiment, but overall impact remains limited.

No significant regional effects expected.

Minimal

Counterpoint

While the news highlights intraday movements, these may be temporary and not indicative of longer-term trends.

Key entities

  • Agape ATP

    A healthcare company experiencing significant intraday gains.

  • Akanda

    A healthcare stock with minimal sentiment impact.

  • Co-Diagnostics

    A diagnostics company showing notable intraday movement.

  • WORK Medical Tech Gr

    A healthcare stock experiencing declines.

  • Wellgistics Health

    A healthcare company with decreased stock value.

Related articles

$AKANHighAI 8/10

Dow, S&P 500, Nasdaq Futures Climb On Tech Earnings Optimism: AKAN, AAPL, RDDT, RIVN Stocks In Focus

U.S. stock futures rose overnight due to strong tech earnings, with Dow, S&P 500, and Nasdaq futures up 0.18%, 0.20%, and 0.11% respectively. Apple (AAPL) beat Q2 expectations, while Alphabet (GOOG, GOOGL) and Amazon (AMZN) also reported strong results. Akanda (AKAN) surged over 40% on drug reclassification optimism. Reddit (RDDT) shares rose 12% on strong Q1 earnings, while Rivian (RIVN) fell 4% on lack of new details about its R2 SUV.

$AVAVLowAI 8/10

Jim Cramer Highlights AeroVironment’s (AVAV) Steep Competition

Jim Cramer advised against investing in AeroVironment (AVAV) despite a 40% stock drop, citing intense competition in the defense sector. The company reported record revenue of $1.98B for FY2026, up 141% YoY, driven by strong defense demand and a $464.8M U.S. Army contract. However, competition from firms like RTX and Lockheed Martin may pressure margins. Hedge fund interest grew, but short interest remains high at 9.55%.

$ANIPLow

ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board

ANI Pharmaceuticals (ANIP) appointed Henry Gosebruch to its board, replacing Muthusamy Shanmugam, who will remain in operational roles. Gosebruch has biotech leadership experience. The company, with a $1.6b market cap, develops and markets branded and generic drugs. Board changes may influence capital allocation and product mix.

$GDMedAI 9/10

General Dynamics wins $249m in US military contracts

General Dynamics (GD) won two U.S. military contracts totaling $248.9M. One is a $149.6M contract for USS Pinckney modernization, with potential value up to $149.9M. The other is a $99.3M task order for MUOS Ground Infrastructure Segment upgrades. Both contracts are sole-source and involve work through 2028, funded by fiscal 2026 budgets.

$LMTHighAI 9/10

Lockheed Martin wins $150 million in defense contracts

Lockheed Martin Corp received three contract modifications worth over $150 million from the U.S. Department of Defense. The largest, $90.2 million, is for the TRIDENT II Life Extension 2 program, with work spread across multiple locations. The other contracts, $40.1 million and $20.3 million, are for the MK 41 Vertical Launching System and HH-60W repairs, respectively. Completion dates range from 2027 to 2030.